PHARMAVITAE 2000: ASTRAZENECA - DATAMONITOR - 2000/07/13 - TF Market Research

Report title: PHARMAVITAE 2000: ASTRAZENECA

from TF Market Research
146 page report published Jul 13, 2000

Price $5,840.00 available for immediate download
This report is also available for purchase on a per-page basis.

Report Overview

Purchase by Section

About TF Market Research

Source:

DATAMONITOR

Company:

ASTRAZENECA

Geographic Regions:

EUROPE, UNITED KINGDOM/GREAT BRITAIN/BRITISH ISLES, WESTERN EUROPE REGION

Format:

PDF

Sections
	Title	Starting Page	Number of Pages
	Introduction To Datamonitor	2	1
	Executive Summary	14	5
	Company Strategy	19	6
	Portfolio & Pipeline Analysis	26	63
	Table/Chart: Ethical Sales From AstraZeneca's Main Therapy Areas 1998-99	27	1
	Table/Chart: AstraZeneca's Gastrointestinal Portfolio 1999	31	1
	Table/Chart: AstraZeneca's Marketed Gastrointestinal Products 1998-99	32	1
	Table/Chart: Patent Expiry Dates For Losec	34	1
	Table/Chart: AstraZeneca's Gastrointestinal R&D Pipeline 1999	38	1
	Table/Chart: Sales In AstraZeneca's Gastrointestinal Portfolio 1999-2005	39	1
	Table/Chart: AstraZeneca's Cardiovascular Portfolio 1999	41	2
	Table/Chart: AstraZeneca's Marketed Cardiovascular Products 1998-99	43	1
	Table/Chart: AstraZeneca's Cardiovascular R&D Pipeline 1999	49	1
	Table/Chart: Sales In AstraZeneca's Cardiovascular Portfolio 1999-2005	51	1
	Table/Chart: AstraZeneca's CNS Portfolio 1999	52	2
	Table/Chart: AstraZeneca's Marketed CNS Products 1998-99	55	1
	Table/Chart: AstraZeneca's CNS R&D Pipeline 1999	58	1
	Table/Chart: Sales In AstraZeneca's CNS Portfolio 1999-2005	61	1
	Table/Chart: AstraZeneca's Cancer Portfolio 1999	62	1
	Table/Chart: AstraZeneca's Marketed Cancer Products 1998-99	63	1
	Table/Chart: AstraZeneca Cancer R&D Pipeline 1999	68	1
	Table/Chart: Sales In AstraZeneca's Cancer Portfolio 1999-2005	70	1
	Table/Chart: AstraZeneca's Respiratory Portfolio 1999	71	2
	Table/Chart: AstraZeneca's Marketed Respiratory Products 1998-99	73	1
	Table/Chart: Respiratory R&D Pipeline 1999	77	1
	Table/Chart: Sales In AstraZeneca's Respiratory Portfolio 1999-2005	79	1
	Table/Chart: AstraZeneca's Anti-Infectives Portfolio 1999	80	1
	Table/Chart: AstraZeneca's Marketed Anti-Infectives Products 1998-99	81	1
	Table/Chart: AstraZeneca Anti-Infectives R&D Pipeline 1999	82	1
	Table/Chart: Sales In AstraZeneca's Anti-Infectives Portfolio 1999-2005	83	1
	Table/Chart: AstraZeneca's Non-Key Marketed Products 1998-99	84	1
	Table/Chart: Sales Of AstraZeneca's Key Therapeutic Portfolios 1999-2005	85	1
	Financial Strategy	89	13
	Geographic Strategy	103	6
	Table/Chart: Key Product Sales In The Seven Major Geographic Mkts. 1998	107	1
	Table/Chart: Ethical Sales Of The Top 20 Pharmaceutical Cos. 1998-99	109	1
	Supporting Data	110	13
	Table/Chart: AstraZeneca's Sales By Product 1998-99	110	3
	Table/Chart: AstraZeneca's Research & Development Pipeline 1999	112	3
	Table/Chart: Exchange Rates 1999	115	1
	Table/Chart: Profit & Loss Account: AstraZeneca 1997-99	116	1
	Table/Chart: Balance Sheet: AstraZeneca 1998-99	117	1
	Table/Chart: Cash Flow Statement For AstraZeneca 1997-99	118	1
	Table/Chart: Key Financial Ratios: AstraZeneca 1997-99	119	1
	Table/Chart: Geographic Distr. Of AstraZeneca's Pharm. Sales 1998-99	120	1
	Datamonitor's Pharm. Research Program Methodology	123	24
	Table/Chart: Stepwise Research Methodology For SPRINT	125	1
	Table/Chart: Universal Datamonitor Classification Of R&D Phases	145	1
	Table/Chart: Average Time Spent In Each Phase Of R&D 1998	146	1
	Table/Chart: Probabilities Of A Drug Successfully Reaching The Mkt. 1998	146	1

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

Price: $5,840.00

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Get FREE Research

Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.